Duloxetine News and Research

RSS
Duloxetine is approved in the United States for the acute and maintenance treatment of major depressive disorder, the acute treatment of generalized anxiety disorder, and the management of diabetic peripheral neuropathic pain and fibromyalgia in adults aged 18 years and older. Duloxetine is not approved for use in pediatric patients.
Most antidepressants are ineffective at treating children and teens, study shows

Most antidepressants are ineffective at treating children and teens, study shows

Nutritional supplements can enhance effectiveness of antidepressants

Nutritional supplements can enhance effectiveness of antidepressants

Botulinum toxin A injections combat neuropathic pain

Botulinum toxin A injections combat neuropathic pain

Unmet medication need in neuropathic pain

Unmet medication need in neuropathic pain

AVACEN Medical launches $2M campaign in response to positive outcomes of fibromyalgia study

AVACEN Medical launches $2M campaign in response to positive outcomes of fibromyalgia study

Breckenridge announces launch of Duloxetine Delayed-release Capsules

Breckenridge announces launch of Duloxetine Delayed-release Capsules

Study compares effectiveness of duloxetine and fluoxetine in children with MDD

Study compares effectiveness of duloxetine and fluoxetine in children with MDD

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

Vitamin D may be adjunct for patients with fibromyalgia syndrome, say researchers

Vitamin D may be adjunct for patients with fibromyalgia syndrome, say researchers

IQWiG completes first health economic evaluation

IQWiG completes first health economic evaluation

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Duloxetine drug alleviates pain from chemotherapy

Duloxetine drug alleviates pain from chemotherapy

Duloxetine drug reduces painful chemotherapy-induced peripheral neuropathy in majority of patients

Duloxetine drug reduces painful chemotherapy-induced peripheral neuropathy in majority of patients

Pelvic floor muscle training effective for adult women with urinary incontinence

Pelvic floor muscle training effective for adult women with urinary incontinence

Antidepressants can play a key role in relieving pain associated with OA

Antidepressants can play a key role in relieving pain associated with OA

UTHealth to study BMS-820836 in Phase II trial for major depressive disorder

UTHealth to study BMS-820836 in Phase II trial for major depressive disorder

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

New guideline on most effective treatments for diabetic nerve pain

New guideline on most effective treatments for diabetic nerve pain

NAFC honors Florida's Cleveland Clinic physician with Continence Care Champion Award

NAFC honors Florida's Cleveland Clinic physician with Continence Care Champion Award

Prolonged exposure to antidepressants can induce tardive dysphoria

Prolonged exposure to antidepressants can induce tardive dysphoria